#usa #investment - We’re in an AI arms race: Palantir Technologies Inc. (PLTR) CEO; Fox Business

27 October 2025

'The Claman Countdown' guests Alex Karp and Kate Johnson discuss efforts to speed up the nation's data superhighways and the multimillion-dollar partnership between Palantir Technologies Inc. (PLTR) and Lumen Technologies, Inc. (LUMN)

#fox #foxnews #media #breakingnews #us #usa #new #news #breaking #theclamancountdown #foxbusiness #alexkarp #karp #katejohnson #johnson #palantir #lumen #ai #artificialintelligence #technology #innovation #datainfrastructure #supercomputing #digitaltransformation #partnership #business #economy #cybersecurity #defense #techindustry #future #politics #government

20 June 2025

British author and investigative journalist Carole Cadwalladr says Americans are living in a surveillance state and she is sounding the alarm about the dangers of techno-authoritarianism. Cadwalladr joins the show to discuss the Trump administration's decision to engage the data analytics company Palantir Technologies.

#usa #investment - Optimism for U.S. and China Deal Lifts Sentiment: Schwab Network

27 October 2025

Stocks are set to kick off the week on a high note as optimism around a U.S.-China trade deal lifts the market. Kevin Green notes that a potential deal or framework announcement this week could be the catalyst for a S&P 500 (SPX) push to new highs.

With positive earnings on the docket, including from tech giants like Apple (AAPL), Microsoft (MSFT) and Alphabet (GOOGL), plus a lack of economic data, the stage is set for a potential "Santa Claus" rally.

KG also discusses a potential rotation back into mega-cap names and notes that small-cap and biopharma stocks are catching bids.

#Switzerland #Investment - Novartis AG (NVS) Agrees $12 Billion Biotech Deal for Avidity: Bloomberg Television

27 October 2025

Novartis (NVS) agreed to buy biotechnology company Avidity in a deal valued at $12 billion, making it the Swiss drugmaker’s biggest acquisition in more than a decade and adding several potential blockbuster treatments as generic competition looms for its current top-sellers.

Sam Fazeli of Bloomberg Intelligence has more.

AI-Powered Stock Picking

danelfin - smart investing made easy

Trade Idea of the Week: ROAD (Construction Partners)

Construction Partners is a BUY for Danelfin AI. We highlight every week a stock with a high win rate track record.

#Spain #Investment - Clínica Baviera, S.A. (CBAV.MC) 1 Semestre 2025 ...... analysis (en español) gracias Company Data View

(Análisis 1S 2025) ¿Es UK un AGUJERO Millonario? Baviera, Vende más pero Gana un 5% MENOS.

26 Octobre 2025

Clínica Baviera, S.A. (CBAV.MC)

La respuesta está en el "agujero en UK". En este análisis financiero a fondo, desgranamos los resultados del primer semestre de 2025 de Clínica Baviera para descubrir la verdad detrás de su gran apuesta en el Reino Unido. ¿Es la adquisición de Optimax una inversión estratégica de futuro o un error que está costando millones?

Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine.

Spain's Best Regions to Live, Retire and Buy Property In